Immune Responses After Vaccination With Primary 2-Dose ChAdOx1 Plus a Booster of BNT162b2 or Vaccination With Primary 2-Dose BNT162b2 Plus a Booster of BNT162b2 and the Occurrence of Omicron Breakthrough Infection

BACKGROUND: Before the omicron era, health care workers were usually vaccinated with either the primary 2-dose ChAdOx1 nCoV-19 (Oxford-AstraZeneca) series plus a booster dose of BNT162b2 (Pfizer-BioNTech) (CCB group) or the primary 2-dose BNT162b2 series plus a booster dose of BNT162b2 (BBB group) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Seong-Ho, Park, Ji Young, Kweon, Oh Joo, Park, Joung Ha, Kim, Min-Chul, Lim, Yaeji, Chung, Jin-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202617/
https://www.ncbi.nlm.nih.gov/pubmed/37218354
http://dx.doi.org/10.3346/jkms.2023.38.e155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202617/
https://www.ncbi.nlm.nih.gov/pubmed/37218354
http://dx.doi.org/10.3346/jkms.2023.38.e155

Ejemplares similares